These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Stable antimicrobial susceptibility rates for clinical isolates of Pseudomonas aeruginosa from the 2001-2003 tracking resistance in the United States today surveillance studies. Karlowsky JA, Jones ME, Thornsberry C, Evangelista AT, Yee YC, Sahm DF. Clin Infect Dis; 2005 Feb 15; 40 Suppl 2():S89-98. PubMed ID: 15712102 [Abstract] [Full Text] [Related]
45. The antibiotic resistance profiles of Pseudomonas aeruginosa in the Asia Cornea Society Infectious Keratitis Study. Khor WB, Lakshminarayanan R, Periayah MH, Prajna VN, Garg P, Sharma N, Mehta JS, Young A, Goseyarakwong P, Puangsricharern V, Tan AL, Beuerman RW, Tan DT, ACSIKS GROUP. Int Ophthalmol; 2024 Aug 31; 44(1):361. PubMed ID: 39215853 [Abstract] [Full Text] [Related]
46. In vitro efficacy of various antibiotic combinations against Pseudomonas aeruginosa isolates. Nazli E, Zer Y, Eksi F. J Int Med Res; 2015 Apr 31; 43(2):217-25. PubMed ID: 25547417 [Abstract] [Full Text] [Related]
47. Antimicrobial activity of tobramycin against respiratory cystic fibrosis Pseudomonas aeruginosa isolates from Bulgaria. Strateva T, Petrova G, Mitov I. J Chemother; 2010 Dec 31; 22(6):378-83. PubMed ID: 21303744 [Abstract] [Full Text] [Related]
48. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital. Raja NS, Singh NN. J Microbiol Immunol Infect; 2007 Feb 31; 40(1):45-9. PubMed ID: 17332906 [Abstract] [Full Text] [Related]
49. New species-related MIC breakpoints for early detection of development of resistance among gram-negative bacteria in Swedish intensive care units. Hanberger H, Nilsson LE, Claesson B, Kärnell A, Larsson P, Rylander M, Svensson E, Sörberg M, Sörén L. J Antimicrob Chemother; 1999 Nov 31; 44(5):611-9. PubMed ID: 10552977 [Abstract] [Full Text] [Related]
50. [Antibiotic susceptibility rates and beta-lactam resistance mechanisms of Pseudomonas aeruginosa strains]. Aktaş Z, Satana D, Kayacan C, Can B, Gönüllü N, Küçükbasmacı O. Mikrobiyol Bul; 2012 Jul 31; 46(3):386-97. PubMed ID: 22951651 [Abstract] [Full Text] [Related]
51. Bactericidal activity of levofloxacin and ciprofloxacin on clinical isolates of different phenotypes of Pseudomonas aeruginosa. Segatore B, Setacci D, Perilli M, Franceschini N, Marchetti F, Amicosante G. Int J Antimicrob Agents; 2000 Jan 31; 13(3):223-6. PubMed ID: 10724029 [Abstract] [Full Text] [Related]
52. Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections. Van Eldere J. J Antimicrob Chemother; 2003 Feb 31; 51(2):347-52. PubMed ID: 12562701 [Abstract] [Full Text] [Related]
53. Comparison of imipenem and five other antipseudomonal agents against gentamicin-susceptible and -resistant Pseudomonas aeruginosa. Gerçeker AA, Otük G. Chemotherapy; 1995 Feb 31; 41(5):334-6. PubMed ID: 8521734 [Abstract] [Full Text] [Related]
54. Cross-resistance of Pseudomonas aeruginosa to ciprofloxacin, extended-spectrum beta-lactams, and aminoglycosides and susceptibility to antibiotic combinations. Chow AW, Wong J, Bartlett KH, Shafran SD, Stiver HG. Antimicrob Agents Chemother; 1989 Aug 31; 33(8):1368-72. PubMed ID: 2508546 [Abstract] [Full Text] [Related]
55. Evaluation of the VITEK 2 system for the identification and susceptibility testing of three species of nonfermenting gram-negative rods frequently isolated from clinical samples. Joyanes P, del Carmen Conejo M, Martínez-Martínez L, Perea EJ. J Clin Microbiol; 2001 Sep 31; 39(9):3247-53. PubMed ID: 11526158 [Abstract] [Full Text] [Related]
56. Susceptibility of Pseudomonas aeruginosa clinical isolates in Japan to doripenem and other antipseudomonal agents. Fujimura T, Anan N, Sugimori G, Watanabe T, Jinushi Y, Yoshida I, Yamano Y. Int J Antimicrob Agents; 2009 Dec 31; 34(6):523-8. PubMed ID: 19748767 [Abstract] [Full Text] [Related]
57. Comparison of Clinical Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing guidelines for the interpretation of antibiotic susceptibility at a University teaching hospital in Nairobi, Kenya: a cross-sectional study. Kassim A, Omuse G, Premji Z, Revathi G. Ann Clin Microbiol Antimicrob; 2016 Apr 11; 15():21. PubMed ID: 27068515 [Abstract] [Full Text] [Related]
58. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center. Ciofu O, Giwercman B, Pedersen SS, Høiby N. APMIS; 1994 Sep 11; 102(9):674-80. PubMed ID: 7946270 [Abstract] [Full Text] [Related]
59. Susceptibility of Ocular Staphylococcus aureus to Antibiotics and Multipurpose Disinfecting Solutions. Afzal M, Vijay AK, Stapleton F, Willcox MDP. Antibiotics (Basel); 2021 Oct 03; 10(10):. PubMed ID: 34680784 [Abstract] [Full Text] [Related]
60. Survey of antibiotic resistance in Pseudomonas aeruginosa by The Tokyo Johoku Association of Pseudomonas Studies. Kato K, Iwai S, Kumasaka K, Horikoshi A, Inada S, Inamatsu T, Ono Y, Nishiya H, Hanatani Y, Narita T, Sekino H, Hayashi I, Tokyo Johoku Association of Pseudomonas Studies. J Infect Chemother; 2001 Dec 03; 7(4):258-62. PubMed ID: 11810595 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]